EBS News and Press, Emergent Biosolutions Inc. From 05/23/22

As monkeypox cases continue to rise worldwide, a group of companies focused on therapeutics and vaccines targeted at a close relative of the virus has extended their recent gains in the pre-market on Monday. Monkeypox is a rare viral disease most common in remote parts of Central and West Afr...

Pharma companies focused on vaccines and therapeutics against the smallpox virus surged this week amid an ongoing outbreak of its close relative, monkeypox. However, their recent price performance and valuations suggest further upside ahead. The World Health Organization said on Friday that o...

The United States is likely to detect additional cases of monkeypox virus in the coming days, but the risk to the general public remains low at this time, a senior U.S. administration official said Friday. In the U.S., the first confirmed case of monkeypox was reported by the Massachusetts De...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Inflation is continuing problem for the stock market. Musk and Twitter are still hashing out their acquisition deal. Prices for consumer goods will likely keep increasing. Source: Shutterstock It’s been...

Update 11:55 AM EST: The World Health Organization's European head raised concerns on Friday that the current spread of monkeypox in the region could worsen as people gather for parties and festivals over the summer. "As we enter the summer season in the European region, with mass gather...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Officials have discovered the first case of monkeypox in the U.S. this year, sparking interest in monkeypox stocks Monkeypox is a rare disease with similarities to smallpox Now various smallpox vaccine stocks are cli...

Smallpox drug maker, SIGA Technologies (NASDAQ:SIGA) is trading higher for the third straight session to reach the highest level since June 2011 amid an ongoing outbreak of monkeypox virus in the west. The World Health Organization is reportedly convening a group of leading experts on the rar...

Shares of Emergent BioSolutions (NYSE: EBS) were soaring by 12.1% as of 10:34 a.m. ET on Thursday. The big gain came as concerns increased about a monkeypox outbreak in Europe. Monkeypox cases are also being investigated in the U.S. and Canada. Emergent BioSolutions makes ACAM20...

Drugmakers targeting vaccines and therapeutics for Monkeypox are trading higher in the morning hours Thursday as countries from the U.S. to Portugal report more cases of the virus. The U.S. has confirmed one infection and 13 suspected cases are under investigation in Canada. Portugal and Spai...

Indaptus Therapeutics (INDP) +22% on FDA nod to begin phase 1 trial of Decoy20 for solid tumors. Zealand Pharma (ZEAL) +19% announces positive results from phase 3 trial of dasiglucagon in pediatric patients with congenital hyperinsulinism.  CBAK Energy Technology (CBAT)&#...